First City Capital Management, Inc.
Source: SEC Form 13F · as of Mar 2026First City Capital Management, Inc. holds 16 biotech & pharma companies tracked by BioSniper, totaling $24.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$24.4M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 6,122 | $5.6M |
| ABBVAbbVie Inc. | 24,349 | $5.3M |
| JNJJOHNSON & JOHNSON | 10,637 | $2.6M |
| MRKMerck & Co., Inc. | 18,503 | $2.2M |
| PMPhilip Morris International Inc | 7,833 | $1.3M |
| BMYBRISTOL MYERS SQUIBB CO | 19,445 | $1.2M |
| AMGNAMGEN INC | 3,282 | $1.2M |
| PFEPFIZER INC | 35,889 | $1.0M |
| MCKMcKesson Corporation | 925 | $800K |
| AZNASTRAZENECA PLC | 3,644 | $719K |
| NVSNovartis AG | 4,321 | $660K |
| ABTABBOTT LABORATORIES | 5,937 | $610K |
| SNYSanofi | 11,020 | $531K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,399 | $379K |
| GILDGILEAD SCIENCES, INC. | 2,175 | $303K |
| IRDOpus Genetics, Inc. | 11,836 | $54K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.